Skip to content
NI
Public company · Nasdaq: NVAX

Updated:

NOVAVAX INC

NOVAVAX INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001000694, and its reported industry is...

Overview

NOVAVAX INC is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001000694, and its reported industry is Biological Products, (No Diagnostic Substances). In 10-K filed on 2026-02-26, it reported annual revenue of USD 1,123,479,000; net income of USD 440,302,000; total assets of USD 1,176,512,000 for the fiscal period ended 2025-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

Company overview

Legal name
NOVAVAX INC
Classification
Public company
Industry (SIC)
2836 — Biological Products, (No Diagnostic Substances)
Headquarters
Gaithersburg, MD, United States
Incorporated in
DE
Fiscal year end
December 31
Ticker
Nasdaq: NVAX
SEC CIK
0001000694

Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

Fiscal yearPeriod endRevenueNet incomeTotal assetsCash and equivalentsOperating cash flow
FY2025USD$1.1B$440.3M$1.2B$240.6M-$244.6M
FY2024USD$682.2M-$187.5M$1.6B$530.2M-$87.3M
FY2023USD$983.7M-$545.1M$1.8B$568.5M-$714.0M
FY2022USD$2.0B-$657.9M$2.3B$1.3B-$415.9M

Recent SEC filings

FormFiledPeriodFiling
8-K8-K
10-Q10-Q
8-KFORM 8-K
8-K8-K
10-Q10-Q
DEF 14ADEF 14A
8-K8-K
10-K10-K
8-KFORM 8-K
8-KFORM 8-K
8-K8-K
10-Q10-Q

Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.

Research NOVAVAX INC in Altss

Track this company’s investors, transactions and relationships in Altss.

Book a demo

More Public Company profiles

NOVAVAX INC (Nasdaq: NVAX) — company profile | Altss